Hims & Hers stock falls 10% on revenue miss
-
最新报道：Hims & Hers Health reported better-than-expected Q2 2025 earnings, with revenue rising 45% year-over-year to $289 million, surpassing analysts' estimates of $275 million. The telehealth company's net loss narrowed to $12 million from $18 million a year earlier, as subscription growth in hair loss and mental health treatments drove profitability. CEO Andrew Dudum highlighted expanding insurance coverage and new weight-loss drug offerings as key growth drivers. Shares surged 8% in after-hours trading following the earnings beat. The company raised its full-year revenue guidance to $1.15-$1.2 billion, up from prior forecasts of $1.1-$1.15 billion.
下一篇
Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more
- Palantir (PLTR) shares surged 8% in after-hours trading following better-than-expected Q2 ...
24小时热点
财联社10月28日电，英伟达与甲骨文宣布扩大合作，将NVIDIA Vera Rubin架构的部署规模扩展至多吉瓦级别，并将NVIDIA Vera CPU引入甲骨文云基础设施（OCI）
币界网消息，财联社10月28日电，英伟达与甲骨文宣布扩大合作 ...
0
热点专题
417090